News Image

Merus Announces Petosemtamab in Metastatic Colorectal Cancer Abstract Selected for Plenary Session Oral Presentation at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

Provided By GlobeNewswire

Last update: Oct 13, 2025

-   Plenary session oral presentation: Friday, October 24 10:00 -11:40 a.m. ET

-   Poster presentation on preclinical evaluation of petosemtamab on cancer stem cells: Friday, October 24 12:30-4:00 p.m. ET

Read more at globenewswire.com

MERUS NV

NASDAQ:MRUS (11/14/2025, 8:06:31 PM)

After market: 95.95 0 (0%)

95.95

-0.13 (-0.14%)



Find more stocks in the Stock Screener

Follow ChartMill for more